Pfizer Study: A Longitudinal Study to Evaluate the Efficacy of Bapineuzumab in Apolipoprotein E ε4 Carriers for the Treatment of Alzheimer’s Disease
The PI of this project was: Sanjay Asthana, MD
This project was funded by: Wyeth Pharmaceuticals, Inc.
The term of this project was: June 2010 to December 2014
The number of subjects scanned during this project was: 5